Po-entecavir (2020-04-15)

APO-Entecavir Recall Summary APO-Entecavir, an antiviral medication, has been recalled across Canada due to product safety concerns. The recall is classified as Class I, which indicates a serious safety issue. This recall affects all patients who have been dispensed this medication in Canada.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2020-04-15
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/12484661-88f7-4544-9fc3-16c9b967e801